10.1021/bi1005514.s001 Roberto T. Bossi Roberto T. Bossi M. Beatrice Saccardo M. Beatrice Saccardo Elena Ardini Elena Ardini Maria Menichincheri Maria Menichincheri Luisa Rusconi Luisa Rusconi Paola Magnaghi Paola Magnaghi Paolo Orsini Paolo Orsini Nilla Avanzi Nilla Avanzi Andrea Lombardi Borgia Andrea Lombardi Borgia Marcella Nesi Marcella Nesi Tiziano Bandiera Tiziano Bandiera Gianpaolo Fogliatto Gianpaolo Fogliatto Jay A. Bertrand Jay A. Bertrand Crystal Structures of Anaplastic Lymphoma Kinase in Complex with ATP Competitive Inhibitors American Chemical Society 2010 ALK kinase domain ATP helical segment crystal structures InhibitorsAnaplastic lymphoma kinase DFG motif Anaplastic Lymphoma Kinase ALK inhibitors receptor tyrosine kinase activation process crystal Structures 2010-08-17 00:00:00 Journal contribution https://acs.figshare.com/articles/journal_contribution/Crystal_Structures_of_Anaplastic_Lymphoma_Kinase_in_Complex_with_ATP_Competitive_Inhibitors/2742238 Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase involved in the development of several human cancers and, as a result, is a recognized target for the development of small-molecule inhibitors for the treatment of ALK-positive malignancies. Here, we present the crystal structures of the unphosphorylated human ALK kinase domain in complex with the ATP competitive ligands PHA-E429 and NVP-TAE684. Analysis of these structures provides valuable information concerning the specific characteristics of the ALK active site as well as giving indications about how to obtain selective ALK inhibitors. In addition, the ALK-KD−PHA-E429 structure led to the identification of a potential regulatory mechanism involving a link made between a short helical segment immediately following the DFG motif and an N-terminal two-stranded β-sheet. Finally, mapping of the activating mutations associated with neuroblastoma onto our structures may explain the roles these residues have in the activation process.